PubMed Health⌕ Search

PubMed · 10901444

Transmembrane versus soluble stem cell factor expression in human testis.

Abstract

The interaction between stem cell factor (SCF), a ligand produced by Sertoli cells, and its c-kit receptor on germ cells is necessary for successful spermatogenesis in animal models. SCF can be alternatively spliced into soluble and transmembrane forms, and it is the transmembrane form that is required for spermatogenesis in rodents. c-Kit receptors are also present on Leydig cells, and soluble SCF has been implicated in the regulation of testosterone production. This study had two goals: To test the hypothesis that the extent of germ cell production in human males is correlated with the expression of transmembrane SCF, and to examine the relationship between testosterone production and the expression of soluble SCF in humans. Reverse transcriptase polymerase chain reaction was used to determine the ratio of transmembrane-to-soluble SCF in testicular tissue. Clinical analysis, hormonal measurements, and histological methods were used to evaluate the causes of infertility and to seek correlations with the pattern of SCF expression. SCF was preferentially expressed as the transmembrane type in all testicular samples, regardless of the state of germ cell production. Furthermore, the percent of transmembrane SCF expression was independent of clinical and histopathological diagnosis (r(s) = 0.111, n = 28) and unrelated to the extent of spermatogenesis. This contrasts with rat models of testicular injury that exhibit a decreased proportion of transmembrane SCF with atrophy. A significant correlation (r(s) = 0.665, P < .02, n = 16) was found between testosterone levels and percent soluble SCF, which suggests that, in humans, there may be a regulatory interaction between soluble SCF and testosterone.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R A Fox, M Sigman, K Boekelheide. Transmembrane versus soluble stem cell factor expression in human testis.. https://pubmed.ncbi.nlm.nih.gov/10901444/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.

BACKGROUND: In fair-skinned Caucasian populations both the incidence and mortality rates of cutaneous melanoma have been increasing over the past decades. With adjuvant therapies still being under investigation, early detection is the only way to improve melanoma patient survival. The influence of incisional biopsies on melanoma patient survival has been discussed for many years. This study investigates both the influence of diagnostic biopsy type and the presence of residual tumor cells in the re-excision specimen on disease free and overall survival. METHODS: After (partial) removal of a pigmented skin lesion 471 patients were diagnosed with stage I/II melanoma and underwent re-excision and a sentinel node biopsy. All patients were followed prospectively, mean follow up >5 years. Patients were divided according to their diagnostic biopsy type (wide excision biopsy, narrow excision biopsy, excision biopsy with positive margins and incisional biopsy) and the presence of residual tumor cells in their re-excision specimen. Survival analysis was done using Cox's proportional hazard model adjusted for eight important confounders of melanoma patient survival. RESULTS: The diagnostic biopsy was wide in 279 patients, narrow in 109 patients, 52 patients underwent an excision biopsy with positive margins and 31 patients an incisional biopsy. In 41 patients residual tumor cells were present in the re-excision specimen. Both the diagnostic biopsy type and the presence of tumor cells in the re-excision specimen did not influence disease free and overall survival of melanoma patients. CONCLUSIONS: Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.

Biopsy↗